search
Back to results

Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial (PCL/TCP)

Primary Purpose

Fractures, Enophthalmos, Diplopia

Status
Unknown status
Phase
Phase 2
Locations
Singapore
Study Type
Interventional
Intervention
Polycaprolactone / Tri-Calcium Phosphate
Titanium Mesh
Sponsored by
National University Hospital, Singapore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fractures focused on measuring Orbital, fractures, enophthalmos, diplopia, eye

Eligibility Criteria

21 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age 21 y - 70 y
  • both males / females included
  • orbital fractures
  • defect after orbital osteotomies

Exclusion Criteria:

  • patient refusal
  • infection around the orbit / generalised infection
  • Diabetes mellitus
  • allergies to polycaprolactone & its analogues
  • allergies to titanium

Sites / Locations

  • National University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Polycaprolactone / Tricalcium Phosphate

Control

Arm Description

Polycaprolactone / Tricalcium Phosphate group to assess efficacy of new implant

Control group with titanium mesh

Outcomes

Primary Outcome Measures

Enophthalmos
Assess the presence of enophthalmos after reconstruction of the orbital walls at 1 week, 1 month, 3 months, 6 months and 12 months

Secondary Outcome Measures

Diplopia
Assess the evidence of diplopia on follow up at 1 week, 1 month, 3 months, 6 months and 12 months
motility of the globe
assess globe motility on follow up at 1 week, 1 month, 3 months, 6 months, and 12 months

Full Information

First Posted
May 5, 2010
Last Updated
April 24, 2014
Sponsor
National University Hospital, Singapore
search

1. Study Identification

Unique Protocol Identification Number
NCT01119144
Brief Title
Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial
Acronym
PCL/TCP
Official Title
Comparing the Reconstruction of the Orbit Fracture With a Poly Caprolactone / Tri-Calcium Phosphate ( PCL/TCP ) Implant vs. a Titanium Mesh Implant.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Unknown status
Study Start Date
April 2010 (undefined)
Primary Completion Date
March 2015 (Anticipated)
Study Completion Date
March 2015 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
National University Hospital, Singapore

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Hypothesis: Polycaprolactone / Tricalcium Phosphate Orbital (PCL / TCP) Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh implant. In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction Polycaprolactone / Tricalcium Phosphate (PCL / TCP) Titanium Patients to be recruited : 80 randomised equally into the 2 groups age range: 21 - 70 includes orbital wall defects from trauma, after osteotomies excludes patients with Diabetes Mellitus, known allergies to polycaprolactone & its analogues, know allergies to Tricalcium Phosphate & its analogues, infections generalised & around the orbital region Trial Duration: April 2010 - March 2015 Follow up: postoperative 1 week, 1 month, 3 months, 6 months, and 12 months Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment
Detailed Description
Hypothesis: Polycaprolactone / Tricalcium Phosphate (PCL / TCP) Orbital Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction Polycaprolactone / Tricalcium Phosphate (PCL / TCP) Titanium Patients to be recruited : 80 randomised equally into the 2 groups age range: 21 -70 includes orbital wall defects from trauma confirmed by Computer Tomographic (CT) scans, after osteotomies excludes patients with Diabetes Mellitus, known allergies to polycaprolactone & its analogues, know allergies to Tricalcium Phosphate & its analogues, infections generalised & around the orbital region Trial Duration : April 2010 - March 2015 Follow up: postoperative 1 week, 1 month, 3 months, 6 months, and 12 months Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment all patients will be seen & assessed in the Plastic & Ophthalmology outpatient clinics by Principal Investigator (PI) and collaborators End point : endpoint for follow-up is 12 months all patients are assessed for assessed for diplopia, enophthalmos, exophthalmos, visual acuity, mobility of the globe, contour symmetry all patients will have a Computer Tomographic (CT) scan of the orbits at 12 months to assess the bony orbit & orbital volume patients will be discharged from follow up at 12 months if asymptomatic patients with complications will exit the protocol & will be treated on their merits eg. infection - removal of implant, etc Data Management : maintained by the Principal Investigator (PI) under repository of the Research & Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore no data will be released without the permission of the Principal Investigator (PI) & the Research & Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fractures, Enophthalmos, Diplopia
Keywords
Orbital, fractures, enophthalmos, diplopia, eye

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Polycaprolactone / Tricalcium Phosphate
Arm Type
Experimental
Arm Description
Polycaprolactone / Tricalcium Phosphate group to assess efficacy of new implant
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Control group with titanium mesh
Intervention Type
Device
Intervention Name(s)
Polycaprolactone / Tri-Calcium Phosphate
Other Intervention Name(s)
Osteomesh Tri-Calcium Phosphate (TCP)
Intervention Description
Orbital implant for reconstruction of the orbital walls
Intervention Type
Device
Intervention Name(s)
Titanium Mesh
Other Intervention Name(s)
Titanium Orbital mesh
Intervention Description
Titanium mesh for comparison to Polycaprolactone / Tri-Calcium Phosphate (PCL / TCP) mesh
Primary Outcome Measure Information:
Title
Enophthalmos
Description
Assess the presence of enophthalmos after reconstruction of the orbital walls at 1 week, 1 month, 3 months, 6 months and 12 months
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Diplopia
Description
Assess the evidence of diplopia on follow up at 1 week, 1 month, 3 months, 6 months and 12 months
Time Frame
1 year
Title
motility of the globe
Description
assess globe motility on follow up at 1 week, 1 month, 3 months, 6 months, and 12 months
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 21 y - 70 y both males / females included orbital fractures defect after orbital osteotomies Exclusion Criteria: patient refusal infection around the orbit / generalised infection Diabetes mellitus allergies to polycaprolactone & its analogues allergies to titanium
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thiam Chye Lim, MD
Organizational Affiliation
Natioanl University Hospital, Singapore
Official's Role
Principal Investigator
Facility Information:
Facility Name
National University Hospital
City
Singapore
ZIP/Postal Code
119074
Country
Singapore
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thiam Chye Lim
Email
surlimtc@nus.edu.sg
First Name & Middle Initial & Last Name & Degree
Eileen Hing
Email
surhch@nus.edu.sg
First Name & Middle Initial & Last Name & Degree
Thiam Chye Lim, FRCS

12. IPD Sharing Statement

Learn more about this trial

Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial

We'll reach out to this number within 24 hrs